Financial News
Opthea Ltd ADR (NQ: OPT )
2.870
-0.070
(-2.38%)
Streaming Delayed Price
Updated: 12:56 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Opthea Ltd ADR
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea Receives A$8.7 million R&D Tax Incentive
March 07, 2023
From Opthea Limited
Via GlobeNewswire
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1919.png)
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea To Present at SVB Leerink Global Biopharma Conference
February 06, 2023
From Opthea Limited
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 01, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea To Present at Sequire Biotechnology Conference
January 30, 2023
From Opthea Limited
Via GlobeNewswire
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
December 12, 2022
From Opthea Limited
Via GlobeNewswire
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea to Present at the FLORetina 2022 Congress
December 06, 2022
From Opthea Limited
Via GlobeNewswire
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
Opthea to Present at Jefferies London Healthcare Conference
November 10, 2022
From Opthea Limited
Via GlobeNewswire
![](https://ml.globenewswire.com/media/ca66150d-0a71-4cb9-935c-3e316db12335/small/optima-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_966.png?width=1200&height=800&fit=crop)
Citigroup Maintains Buy Rating for Opthea: Here's What You Need To Know
September 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_8798.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6041.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_4644.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3969.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3487.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2544.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3336.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2810.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2724.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/microscope-3184432_1920_201.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_347.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.